Events

View All

    Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen

    October 04, 2022
    Share on:

    Speaker: John Charpentier, Ph.D, Scientific Content Specialist, Biocytogen Boston

     

    • Defined pharmacokinetics/pharmacodynamics (PK/PD) and useful parameters to measure them
    • Discussed Biocytogen’s platforms suited for antibody PK/PD studies
    • Introduced humanized mouse models useful for evaluation of PK/PD
    • In vivo case studies and examples
    • Q&A session

     

    0.233221s